Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder

Schachter HM, Pham B, King J, et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention deficit disorder in children and adolescents: a meta-analysis. CMAJ 2001; 165(11): 1475–88 NIH Consensus Development Program-110. Diagnosis and treatment of attention deficit hyperactivity disorder. Consensus development conference statement. Bethesda (MD): National Institutes of Health, 1998 Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996; 98: 1084–8 Safer DJ, Malever M. Stimulant treatment in Maryland public schools. Pediatrics 2000; 106: 533–9 Zito JM, Safer DJ, dos Reis S, et al. Trends in the prescribing of psychotropic medication to preschoolers. JAMA 2000; 283: 1025–30 Rappley MD, Mullan PB, Alvarez AJ, et al. Diagnosis of attention deficit disorder and the use of psychotropic medication in very young children. Arch Pediatr Adolesc Med 1999; 153: 1039–45 Connor DF. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. J Dev Behav Pediatr 2002; 23 (1 Suppl.): S1–9 Weiss M, Jain U, Garland J. Clinical suggestions for management of stimulant treatment in adolescents. Can J Psychiatry 2000; 45: 717–23 Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention deficit disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35: 409–32 Hechtman L, Abikoff H. Methylphenidate and multimodal treatment in attention deficit hyperactive disorder. In: Jensen PS, Hibbs ED, editors. Psychosocial treatment research with children and adolescents. Washington, DC: APA Press, 1996: 341–69 MTA Cooperative Group, Jensen P, Arnold LE, et al. A 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999; 56: 1073–86 MTA Cooperative Group, Hinshaw S, Swanson J, et al. Moderators and mediators of treatment response for children with ADHD: the MTA Study. Arch Gen Psychiatry 1999; 56: 1088–96 Hechtman L, Abikoff H. Multimodal treatment plus stimulants vs stimulant treatment in ADHD children: results from a two-year comparative treatment study. Annual Meeting of the American Academy of Child and Adolescent Psychiatry; 1995 Oct 18–26; New Orleans (LA) Gillberg C, Melander H, von Knorring A, et al. Long-term central stimulant treatment of children with attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial. Arch Gen Psychiatry 1997; 54: 857–64 Schachar RJ, Tannock R, Cunningham C, et al. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry 1997; 36: 754–63 Weiss G, Kruger E, Danielson U, et al. Effects of long-term treatment of hyperactive children with methylphenidate. CMAJ 1975; 112: 159–65 Loney J, Kramer J, Milich R. The hyperkinetic child grows up: predictors of symptoms, delinquency, and achievement at follow-up. In: Gadow KD, Loney J, editors. Psychosocial aspects of drug treatment for hyperactivity. Boulder (CO): Westview Press, 1981: 381–415 Paternite CE, Loney J, Salisbury H, et al. Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. J Child Adolesc Psychopharmacol 1999; 9(3): 169–84 Blouin AGA, Bornstein R, Trites R. Teen-age alcohol use among hyperactive children: a 5-year follow-up study. J Pediatr Psychol 1978; 3: 188–94 Charles L, Stein R. A four-year follow-up study of the effects of methylphenidate on the behavior and academic achievement of hyperactive children. J Abnorm Child Psychol 1981; 9: 495–505 Satterfield J, Hoppe CM, Schell AM. A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys. Am J Psychiatry 1982; 139: 797–8 Satterfield JH, Satterfield BT, Cantwell DP. Three-year multimodal treatment study of 100 hyperactive boys. J Pediatr 1981; 98: 650–5 Gittelman R, Mannuzza S, Shenker R, et al. Hyperactive boys almost grown-up. Arch Gen Psychiatry 1985; 42: 937–47 Mannuzza S, Klein RG, Bessler A, et al. Adult outcome in hyperactive boys. Arch Gen Psychiatry 1993; 50: 565–76 Barkley RA, Fischer M, Edelbrock CS, et al. The adolescent outcome of hyperactive children diagnosed by research criteria: an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990; 29: 546–57 Fischer M, Barkley RA, Smallish L, et al. Young adult follow-up of hyperactive children: self-report psychiatric disorders comorbidity and the role of childhood conduct problems and teen CD. J Abnorm Child Psychol 2002; 30(5): 463–75 Weiss G, Minde K, Werry J, et al. A five-year follow-up of 91 hyperactive school children. Arch Gen Psychiatry 1971; 24: 409–14 Weiss G, Hechtman L. Hyperactive children grown up. New York: Guilford Press, 1993 Hechtman L, Weiss G, Perlman T, et al. Young adult outcome of hyperactive children who received long-term stimulant treatment. J Am Acad Child Adolesc Psychiatry 1984; 23(3): 261–9 Barkley RA, Fischer M, Smallish L, et al. Does stimulant treatment of ADHD contribute to substance use and abuse: a 13-year prospective study. Pediatrics 2003; 3(1): 97–109 Zeiner P. Body growth and cardiovascular function after extended (1.75 years) with methylphenidate in boys with attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 1995; 5: 129–38 Klein R, Mannuzza S. Hyperactive boys almost grown up (III): methylphenidate effects on ultimate height. Arch Gen Psychiatry 1988; 45: 1131–4 Biederman J, Wilens T, Mick E, et al. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104: E20 Loney J, Kramer J, Salisbury H. Medicated versus unmedicated ADHD children: adult involvement with legal and illegal drugs. In: Jensen P, Cooper JR, editors. Diagnosis and treatment of attention deficit hyperactivity disorder. Kingston (NJ): Civic Research Institute, 2002 Huss M, Lehmkuhl U. Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies. J Atten Disord 2002; 6: S65–71 Burke JD, Loeber R, Lahey BB. Which aspects of ADHD are associated with tobacco use in early adolescence? J Child Psychol Psychiatry 2001; 42: 493–502 Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 1998; 31: 533–44 Conners K, Epstein J, March J, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 2001; 40(2): 159–67 Swanson J, Kraemer H, Hinshaw S, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001; 40(2): 167–79 Biederman J, Lopez F, Boellner S, et al. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 in children with attention deficit/hyperactivity disorder. Pediatrics 2002; 110(2): 1–9 Wolraich ML, Greenhill L, Pelham W, et al. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics 2001; 108(4): 883–92 Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry 1999; 38(5): 503–12 Conrad WG, Insel J. Anticipating the response to amphetamine therapy in the treatment of hyperkinetic children. Pediatrics 1967; 40: 96–8 Wilkinson GS. The wide range achievement test-revised: administration manual. Wilmington (DE): Wide Range, Inc., 1993 Wechsler D. Wechsler adult intelligence scale-III. San Antonio (TX): The Psychological Corporation, 1997 Ackerman PT, Dykman RA, Peters JE. Teenage status of hyperactive and non-hyperactive learning disabled boys. Am J Orthopsychiatry 1977; 47: 577–96 Riddle KD, Rapoport JL. A 2-year follow-up of 72 hyperactive boys. J Nerv Ment Dis 1976; 162: 126–34 Hathaway SR, McKinley JC. Minnesota multiphasic personality inventory-2: manual for administration and scoring. Minneapolis (MN): University of Minnesota Press, 1989 Fischer M, Barkley RA, Fletcher KE, et al. The adolescent outcome of hyperactive children: predictors of psychiatric, academic, social, and emotional adjustment. J Am Acad Child Adolesc Psychiatry 1993; 32(2): 324–32 Lambert N, Hartsaugh C, Sassone D. Persistence of hyperactivity symptoms from childhood to adolescence. Am J Orthopsychiatry 1987; 57: 22–31 Biederman J, Faraone S, Milberger S, et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 1996; 53(5): 437–46 Safer D, Allen R, Barr E. Depression of growth in hyperactive children on stimulant drugs. N Engl J Med 1972; 287: 217–20 Safer DJ, Allen RP. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics 1973; 51: 660–7 Safer DJ, Allen RP, Barr E. Growth rebound after termination of stimulant drugs. Pediatrics 1975; 86: 113–6 Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983; 40: 317–21 Reeve E, Garfinkel B. Neuroendocrine and growth regulations: the role of sympathomimetic medication. In: Greenhill LL, Osmon BB, editors. Ritalin: theory and patient management. New York: Mary Ann Liebert, 1991: 289–300 Spencer TJ, Biederman J, Harding M, et al. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 1996; 35: 1460–9 Goldman L, Genel M, Bezman R, et al. Diagnosis and treatment of attentiondeficit/hyperactivity disorder. JAMA 1998; 279: 1100–7 Volkow N, Wang G, Fowler J, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998; 155: 1325–31 Biederman J, Wilens T, Mick E, et al. Is ADHD a risk factor for psychoactive substance use disorders: findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997; 36(1): 21–9 Hechtman L. Adolescent outcome of hyperactive children treated with stimulants in childhood: a review. Psychopharmacol Bull 1985; 21: 178–91 Kramer J, Loney J, Whaley-Klahn M. The role of prescribed medication in hyperactive youths’ substance use. In: Scientific Proceedings of the American Psychological Association. Los Angeles (CA): American Psychological Association, 1981 Barkley RA, Fischer M, Edelbrock CS, et al. The adolescent outcome of hyperactive children diagnosed by research criteria (III): mother-child interactions, family conflicts and maternal psychopathology. J Child Psychol Psychiatry 1991; 32(2): 233–55 Milberger S, Biederman J, Faraone SV, et al. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36(1): 37–44 Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attentiondeficit/hyperactivity disorder beget later substance abuse: a meta-analytic review of the literature. Pediatrics 2003; 111: 179–85 Barkley RA. Does stimulant treatment medication therapy for ADHD in children predispose to later drug use? ADHD Report 2003; 11(1): 2–7